{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T08:59:04Z","timestamp":1790499544538,"version":"4.1.0"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01746","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T12:57:57Z","timestamp":1564750677000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses"],"prefix":"10.3389","volume":"10","author":[{"given":"Tianyu","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.immuni.2016.04.017","article-title":"Co-stimulatory and co-inhibitory pathways in autoimmunity","volume":"44","author":"Zhang","year":"2016","journal-title":"Immunity."},{"key":"B2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.autrev.2017.03.011","article-title":"Regulatory immune cells and functions in autoimmunity and transplantation immunology","volume":"16","author":"Papp","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/imr.12169","article-title":"Regulatory T cells in autoimmune neuroinflammation","volume":"259","author":"Kleinewietfeld","year":"2014","journal-title":"Immunol Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/bs.pmbts.2015.07.021","article-title":"Regulatory T cells in Arthritis","volume":"136","author":"Komatsu","year":"2015","journal-title":"Prog Mol Biol Transl Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s10753-016-0470-8","article-title":"Foxp3, regulatory T cell, and autoimmune diseases","volume":"40","author":"Tao","year":"2017","journal-title":"Inflammation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.autrev.2014.01.047","article-title":"Diagnosis and classification of autoimmune blistering diseases","volume":"13","author":"Baum","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"17026","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers."},{"key":"B11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2133.2012.11040.x","article-title":"Association between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"167","author":"Yan","year":"2012","journal-title":"Br J Dermatol."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1365-2133.1998.02350.x","article-title":"The association of HLA-DQ7 with bullous pemphigoid is restricted to men","volume":"138","author":"Banfield","year":"1998","journal-title":"Br J Dermatol."},{"key":"B14","first-page":"1","article-title":"Association between HLA-DQB1*03:01 and Bullous pemphigoid in Iranian patients","volume":"10","author":"Esmaili","year":"2013","journal-title":"Iran J Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5021\/ad.2018.30.1.8","article-title":"HLA-C*17, DQB1*03:01, DQA1*01:03 and DQA1*05:05 alleles associated to bullous pemphigoid in brazilian population","volume":"30","author":"Chagury","year":"2018","journal-title":"Ann Dermatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1346-8138.2000.tb02141.x","article-title":"Polymorphisms of HLA-DR and -DQ genes in Japanese patients with bullous pemphigoid","volume":"27","author":"Okazaki","year":"2000","journal-title":"J Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fimmu.2018.00136","article-title":"Pemphigus-a disease of desmosome dysfunction caused by multiple mechanisms","volume":"9","author":"Spindler","year":"2018","journal-title":"Front Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.4049\/jimmunol.181.3.1825","article-title":"Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction","volume":"181","author":"Heupel","year":"2008","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1074\/jbc.M110.172874","article-title":"p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris","volume":"286","author":"Mao","year":"2011","journal-title":"J Biol Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/sj.jid.5700735","article-title":"Nuclear c-Myc: a molecular marker for early stage pemphigus vulgaris","volume":"127","author":"Williamson","year":"2007","journal-title":"J Invest Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9447","DOI":"10.1074\/jbc.M112.438010","article-title":"A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis","volume":"288","author":"Bektas","year":"2013","journal-title":"J Biol Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.4049\/jimmunol.182.1.711","article-title":"Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"23826","DOI":"10.1074\/jbc.M115.668061","article-title":"Critical role of the neonatal Fc receptor (FcRn) in the pathogenic action of antimitochondrial autoantibodies synergizing with anti-desmoglein autoantibodies in pemphigus vulgaris","volume":"290","author":"Chen","year":"2015","journal-title":"J Biol Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.4049\/jimmunol.177.5.3398","article-title":"Role of FcRs in animal model of autoimmune bullous pemphigoid","volume":"177","author":"Zhao","year":"2006","journal-title":"J Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1074\/jbc.M111.221036","article-title":"The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid","volume":"286","author":"Heimbach","year":"2011","journal-title":"J Biol Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"37358","DOI":"10.1074\/jbc.M111.272401","article-title":"Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid","volume":"286","author":"Lin","year":"2011","journal-title":"J Biol Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/s0092-8674(00)00087-8","article-title":"The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B\/MMP-9 in vivo","volume":"102","author":"Liu","year":"2000","journal-title":"Cell."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1172\/JCI8748","article-title":"Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus","volume":"105","author":"Amagai","year":"2000","journal-title":"J Clin Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4049\/jimmunol.181.2.1526","article-title":"Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris","volume":"181","author":"Takahashi","year":"2008","journal-title":"J Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1600-0625.2008.00776.x","article-title":"Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies","volume":"18","author":"Takae","year":"2009","journal-title":"Exp Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","article-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180","volume":"92","author":"Liu","year":"1993","journal-title":"J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12026-008-8028-y","article-title":"Complement and cutaneous autoimmune blistering diseases","volume":"41","author":"Lessey","year":"2008","journal-title":"Immunol Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/2326-6066.CIR-16-0193","article-title":"Regulatory T cells: differentiation and function","volume":"4","author":"Plitas","year":"2016","journal-title":"Cancer Immunol Res."},{"key":"B40","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/ni.3004","article-title":"Continuous requirement for the TCR in regulatory T cell function","volume":"15","author":"Levine","year":"2014","journal-title":"Nat Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.4049\/jimmunol.1600242","article-title":"Role of Metabolism in the Immunobiology of Regulatory T Cells","volume":"197","author":"Galgani","year":"2016","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000099585","article-title":"CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris","volume":"214","author":"Sugiyama","year":"2007","journal-title":"Dermatology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.imbio.2015.06.008","article-title":"Distinctive Treg associated CCR4-CCL22 expression profile with altered frequency of Th17\/Treg cell in the immunopathogenesis of Pemphigus Vulgaris","volume":"220","author":"Asothai","year":"2015","journal-title":"Immunobiology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1684\/ejd.2013.2177","article-title":"The imbalance of Th17 and regulatory T cells in pemphigus patients","volume":"23","author":"Xu","year":"2013","journal-title":"Eur J Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/intimm\/dxr020","article-title":"Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris","volume":"23","author":"Yokoyama","year":"2011","journal-title":"Int Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/exd.12919","article-title":"Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris","volume":"25","author":"Schmidt","year":"2016","journal-title":"Exp Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1159\/000448031","article-title":"Assessment of the effects of rituximab monotherapy on different subsets of circulating T-regulatory cells and clinical disease severity in severe pemphigus vulgaris","volume":"232","author":"Bhattacharjee","year":"2016","journal-title":"Dermatology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coi.2016.09.003","article-title":"Targeting B cells in treatment of autoimmunity","volume":"43","author":"Franks","year":"2016","journal-title":"Curr Opin Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00403-017-1754-z","article-title":"Rituximab treatment in pemphigus vulgaris: effect on circulating Tregs","volume":"309","author":"El-Zawahry","year":"2017","journal-title":"Arch Dermatol Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/immu.200390024","article-title":"Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis","volume":"33","author":"Cao","year":"2003","journal-title":"Eur J Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar1954","article-title":"Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study","volume":"8","author":"Vigna-Perez","year":"2006","journal-title":"Arthritis Res Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1182\/blood-2007-12-129262","article-title":"Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab","volume":"112","author":"Stasi","year":"2008","journal-title":"Blood."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s00415-013-6987-y","article-title":"Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis","volume":"260","author":"Catzola","year":"2013","journal-title":"J Neurol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00403-012-1213-9","article-title":"Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients","volume":"304","author":"Quaglino","year":"2012","journal-title":"Arch Dermatol Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jdv.12091","article-title":"Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid","volume":"28","author":"Antiga","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1600-0625.2006.00522.x","article-title":"Frequency, function and CLA expression of CD4+CD25+FOXP3+ regulatory T cells in bullous pemphigoid","volume":"16","author":"Rensing-Ehl","year":"2007","journal-title":"Exp Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","article-title":"Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?","volume":"30","author":"Curotto de Lafaille","year":"2009","journal-title":"Immunity."},{"key":"B64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev."},{"key":"B65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12929-017-0391-3","article-title":"Regulatory T cells induced by B cells: a novel subpopulation of regulatory T cells","volume":"24","author":"Chien","year":"2017","journal-title":"J Biomed Sci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature."},{"key":"B68","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1365-2567.2008.02932.x","article-title":"Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3","volume":"127","author":"Veldman","year":"2009","journal-title":"Immunology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.4049\/jimmunol.176.5.3215","article-title":"Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells","volume":"176","author":"Veldman","year":"2006","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.humimm.2008.07.016","article-title":"CD8+ regulatory T cells in persistent human viral infections","volume":"69","author":"Billerbeck","year":"2008","journal-title":"Hum Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell."},{"key":"B73","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.humimm.2008.08.283","article-title":"Inhibitory CD8+ T cells in autoimmune disease","volume":"69","author":"Suzuki","year":"2008","journal-title":"Hum Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1182\/blood-2003-04-1320","article-title":"Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes","volume":"102","author":"Cosmi","year":"2003","journal-title":"Blood."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1002\/eji.200526162","article-title":"Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function","volume":"35","author":"Jarvis","year":"2005","journal-title":"Eur J Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1084\/jem.20040395","article-title":"Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis","volume":"200","author":"Rifa'I","year":"2004","journal-title":"J Exp Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.4049\/jimmunol.175.11.7093","article-title":"Cutting edge: CD8+CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells","volume":"175","author":"Endharti","year":"2005","journal-title":"J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/eji.200939314","article-title":"Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg","volume":"39","author":"Shi","year":"2009","journal-title":"Eur J Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1600-6143.2012.04120.x","article-title":"Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells","volume":"12","author":"Lerret","year":"2012","journal-title":"Am J Transplant."},{"key":"B80","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.4049\/jimmunol.166.10.6452","article-title":"Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus","volume":"166","author":"Filaci","year":"2001","journal-title":"J Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"825","DOI":"10.4049\/jimmunol.180.2.825","article-title":"Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis","volume":"180","author":"Lee","year":"2008","journal-title":"J Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"705","DOI":"10.4049\/jimmunol.176.2.705","article-title":"A case for regulatory B cells","volume":"176","author":"Mizoguchi","year":"2006","journal-title":"J Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity."},{"key":"B84","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e49835","DOI":"10.1371\/journal.pone.0049835","article-title":"Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease","volume":"7","author":"Zha","year":"2012","journal-title":"PLoS ONE."},{"key":"B86","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/jir.2010.0020","article-title":"Allergen-specific transforming growth factor-beta-producing CD19+CD5+ regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow's milk","volume":"31","author":"Lee","year":"2011","journal-title":"J Interferon Cytokine Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/MED.0b013e328355461b","article-title":"A role for tolerogenic dendritic cell-induced B-regulatory cells in type 1 diabetes mellitus","volume":"19","author":"Giannoukakis","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B88","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.clim.2014.09.011","article-title":"Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis","volume":"155","author":"Michel","year":"2014","journal-title":"Clin Immunol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"254245","DOI":"10.1155\/2015\/254245","article-title":"The Expansion of CD25 high IL-10 high FoxP3 high B regulatory cells is in association with SLE disease activity","volume":"2015","author":"Vadasz","year":"2015","journal-title":"J Immunol Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jnr.23749","article-title":"Role of regulatory b cells in neuroimmunologic disorders","volume":"94","author":"Han","year":"2016","journal-title":"J Neurosci Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3109\/03009742.2015.1126346","article-title":"Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients","volume":"45","author":"Heinemann","year":"2016","journal-title":"Scand J Rheumatol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1172\/JCI36030","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-1161-5_14","article-title":"Regulatory B cells in mouse models of systemic lupus erythematosus (SLE)","volume":"1190","author":"Matsushita","year":"2014","journal-title":"Methods Mol Biol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-1161-5_17","article-title":"Regulatory B cells in experimental autoimmune encephalomyelitis (EAE)","volume":"1190","author":"Ray","year":"2014","journal-title":"Methods Mol Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-4939-1161-5_13","article-title":"Regulatory B cells in experimental mouse models of arthritis","volume":"1190","author":"Rosser","year":"2014","journal-title":"Methods Mol Biol."},{"key":"B97","first-page":"28","article-title":"Pemphigus: pathogenesis to treatment","volume":"99","author":"DiMarco","year":"2016","journal-title":"R I Med J."},{"key":"B98","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/bjd.13192","article-title":"Impaired function of CD19(+) CD24(hi) CD38(hi) regulatory B cells in patients with pemphigus","volume":"172","author":"Zhu","year":"2015","journal-title":"Br J Dermatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1111\/bjd.15113","article-title":"Decreased level of interleukin-10-producing B cells in patients with pemphigus but not in patients with pemphigoid","volume":"176","author":"Kabuto","year":"2017","journal-title":"Br J Dermatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"175ra130","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/1346-8138.13295","article-title":"Increase of interleukin-10-producing B cells associated with long-term remission after i.v. immunoglobulin treatment for pemphigus","volume":"43","author":"Kabuto","year":"2016","journal-title":"J Dermatol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature."},{"key":"B103","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41598-018-19226-z","article-title":"Dysfunction of CD19(+)CD24(hi)CD27(+) B regulatory cells in patients with bullous pemphigoid","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep."},{"key":"B104","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity."},{"key":"B105","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1600-065X.2011.01015.x","article-title":"Dendritic cell control of tolerogenic responses","volume":"241","author":"Manicassamy","year":"2011","journal-title":"Immunol Rev."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.07.011","article-title":"Regulatory dendritic cells in autoimmunity: a comprehensive review","volume":"63","author":"Liu","year":"2015","journal-title":"J Autoimmun."},{"key":"B107","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"6861","DOI":"10.4049\/jimmunol.166.11.6861","article-title":"Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors","volume":"166","author":"Gerber","year":"2001","journal-title":"J Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1002\/eji.201141717","article-title":"Regulatory macrophages: setting the threshold for therapy","volume":"41","author":"Fleming","year":"2011","journal-title":"Eur J Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am J Transplant."},{"key":"B112","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood."},{"key":"B114","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","article-title":"Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells","volume":"105","author":"Jiang","year":"2005","journal-title":"Blood."},{"key":"B115","doi-asserted-by":"publisher","first-page":"394917","DOI":"10.1155\/2015\/394917","article-title":"Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications","volume":"2015","author":"Castro-Manrreza","year":"2015","journal-title":"J Immunol Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12015-014-9567-3","article-title":"Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during the T cell response: the importance of the IL-10\/CD210 Axis","volume":"11","author":"Najar","year":"2015","journal-title":"Stem Cell Rev."},{"key":"B117","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yexcr.2014.03.013","article-title":"Immunomodulation of mesenchymal stromal cells on regulatory T cells and its possible mechanism","volume":"324","author":"Yan","year":"2014","journal-title":"Exp Cell Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12917-015-0371-3","article-title":"CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus","volume":"11","author":"Han","year":"2015","journal-title":"BMC Vet Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1567-5769(00)00043-6","article-title":"Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases","volume":"1","author":"Miwa","year":"2001","journal-title":"Int Immunopharmacol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/0961203306071916","article-title":"Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia","volume":"15","author":"Garcia-Valladares","year":"2006","journal-title":"Lupus."},{"key":"B123","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.autrev.2006.09.008","article-title":"The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias","volume":"6","author":"Ruiz-Arguelles","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cellimm.2010.07.013","article-title":"Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients","volume":"265","author":"Alegretti","year":"2010","journal-title":"Cell Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1590\/S0482-50042011000500009","article-title":"Expression of complement regulatory proteins CD55, CD59, CD35, and CD46 in rheumatoid arthritis","volume":"51","author":"Piccoli","year":"2011","journal-title":"Rev Bras Reumatol"},{"key":"B126","first-page":"701","article-title":"Complement and membrane-bound complement regulatory proteins as biomarkers and therapeutic targets for autoimmune inflammatory disorders, RA and SLE","volume":"53","author":"Das","year":"2015","journal-title":"Indian J Exp Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jdermsci.2017.07.012","article-title":"IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid","volume":"88","author":"Dainichi","year":"2017","journal-title":"J Dermatol Sci."},{"key":"B128","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41598-017-00235-3","article-title":"Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid","volume":"7","author":"Qiao","year":"2017","journal-title":"Sci Rep."},{"key":"B129","doi-asserted-by":"publisher","first-page":"35517","DOI":"10.18632\/oncotarget.21216","article-title":"Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid","volume":"9","author":"Qiao","year":"2018","journal-title":"Oncotarget."},{"key":"B130","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nm1408","article-title":"Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells","volume":"12","author":"Ochi","year":"2006","journal-title":"Nat Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2337\/db06-1632","article-title":"Inhibition of autoimmune diabetes by oral administration of anti-CD3 monoclonal antibody","volume":"56","author":"Ishikawa","year":"2007","journal-title":"Diabetes."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jjcc.2015.02.002","article-title":"Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease","volume":"66","author":"Yamashita","year":"2015","journal-title":"J Cardiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/molecules22010134","article-title":"Therapeutic potential of targeting the Th17\/Treg axis in autoimmune disorders","volume":"22","author":"Fasching","year":"2017","journal-title":"Molecules."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01746\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T20:03:44Z","timestamp":1695067424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01746\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":133,"alternative-id":["10.3389\/fimmu.2019.01746"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01746","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"article-number":"1746"}}